Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 25, 2016 (11 years ago)

All Malarone

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Processing Controls

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

All Malarone (atovaquone and proguanil) Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.

Drug: Atovaquone

Recalling firm
Reliable Rexall-A Compounding Pharmacy
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1136-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Atovaquone recalls

See all
Class I · High risk

Atovaquone Oral Suspension

Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.

Terminated Microbial contamination Bionpharma Inc. NDC 69452-252-87 D-0012-2025
Class I · High risk

Atovaquone Oral Suspension USP

Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.

Ongoing Microbial contamination Camber Pharmaceuticals Inc. NDC 31722-629-21 D-0567-2023
Class II · Moderate risk

Atovaquone active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-528-2015

Other recalls by Reliable Rexall-A Compounding Pharmacy

All 2016 recalls